
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Check out this week’s headlines
Happy Friday dvm360 readers! Can you believe that we are already in September? Now that we are moving toward fall, that means that Fetch Coastal is quickly approaching! Check into dvm360.com through the next couple of weeks leading up to Fetch Coastal to see sneak peek interviews with speakers to learn more about what you can expect at this year’s Fetch Coastal conference. You can learn more about the conference and register here today!
This week on dvm360.com, here is what was popular:





